Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer
Purpose Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast
cancer that is frequently treated with chemotherapy. However, many patients exhibit either …
cancer that is frequently treated with chemotherapy. However, many patients exhibit either …
The role of epigenomics in the study of cancer biomarkers and in the development of diagnostic tools
M Verma - Advances in Cancer Biomarkers: From biochemistry to …, 2015 - Springer
Epigenetics plays a key role in cancer development. Genetics alone cannot explain sporadic
cancer and cancer development in individuals with no family history or a weak family history …
cancer and cancer development in individuals with no family history or a weak family history …
The most common genes involved in epigenetics modifications among Iranian patients with breast cancer: A systematic review
N Iranshahi, P Zafari, KH Yari… - Cellular and Molecular …, 2016 - cellmolbiol.org
Breast cancer, with a lifelong risk of one in nine, is the most common cancer among women.
In Iran, breast cancer is one of the growing and important women's health problems. Several …
In Iran, breast cancer is one of the growing and important women's health problems. Several …
Validation of DNA promoter hypermethylation biomarkers in breast cancer—a short report
JS De Groot, X Pan, J Meeldijk, E Van Der Wall… - Cellular oncology, 2014 - Springer
Purpose DNA promoter hypermethylation of tumor suppressor genes is known to occur early
in cancer development, including breast cancer. To improve early breast cancer detection …
in cancer development, including breast cancer. To improve early breast cancer detection …
Neuropeptide receptor genes GHSR and NMUR1 are candidate epigenetic biomarkers and predictors for surgically treated patients with oropharyngeal cancer
Pathological staging and histological grading systems are useful, but imperfect, predictors of
recurrence in head and neck squamous cell carcinoma (HNSCC). Aberrant promoter …
recurrence in head and neck squamous cell carcinoma (HNSCC). Aberrant promoter …
[HTML][HTML] GHSR DNA hypermethylation is a common epigenetic alteration of high diagnostic value in a broad spectrum of cancers
EA Moskalev, P Jandaghi, M Fallah, M Manoochehri… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Identification of a single molecular trait that is determinant of common malignancies may
serve as a powerful diagnostic supplement to cancer type-specific markers. Here, we report …
serve as a powerful diagnostic supplement to cancer type-specific markers. Here, we report …
GHSR DNA hypermethylation is a new epigenetic biomarker for gastric adenocarcinoma and beyond
M Amini, K Foroughi, F Talebi… - Journal of Cellular …, 2019 - Wiley Online Library
Aberrations of DNA methylation are early events in the development of tumors. In this study,
we investigated the DNA methylation status of growth hormone secretagogue receptor …
we investigated the DNA methylation status of growth hormone secretagogue receptor …
Investigation of GHSR and GHRL Methylation in Colorectal Cancer
F Coppedè, A Stoccoro, A Lazzarotti, R Spisni… - …, 2018 - Taylor & Francis
Aim: To investigate GHSR and GHRL methylation in 73 pairs of colorectal cancer (CRC)
tissues and healthy adjacent mucosa. Methods: Methylation was assessed with methylation …
tissues and healthy adjacent mucosa. Methods: Methylation was assessed with methylation …
Nuclear colocalization and complex formation of insulin with retinoblastoma protein in HepG2 human hepatoma cells
RT Radulescu, ED Doklea, K Kehe… - Journal of …, 2000 - joe.bioscientifica.com
Genetic variations in ovulation rate which occur in different breeds of sheep provide useful
models to explore the mechanisms regulating the development of antral follicles. The …
models to explore the mechanisms regulating the development of antral follicles. The …
GHSR hypermethylation: a promising pan-cancer marker
P Jandaghi, JD Hoheisel, Y Riazalhosseini - Cell Cycle, 2015 - Taylor & Francis
The advent of high-throughput technologies such as microarrays, global gene knockout, and
next generation sequencing (NGS) has revolutionized the field of molecular oncology. Large …
next generation sequencing (NGS) has revolutionized the field of molecular oncology. Large …